<div id="readability-page-1"><div>Zoetis Inc. (ZTS) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud InvestigationLaw Offices of Howard G. Smith announces an investigation on behalf of Zoetis Inc. (“Zoetis” or the “Company”) (NYSE: ZTS) investors concerning the Company’s possible violations of federal securities laws.IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN ZOETIS INC. (ZTS), CONTACT THE LAW OFFICES OF HOWARD G. SMITH ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS.Contact the Law Offices of Howard G. Smith to discuss your legal rights by email at howardsmith@howardsmithlaw.com, by telephone at (215) 638-4847 or visit our website at www.howardsmithlaw.com.What Happened?On May 7, 2026, Zoetis reported financial results for the first quarter of 2026. Among other items, Zoetis reported net income of $601 million, flat year over year, and cuts to its full year 2026 profit guidance to between $6.85 and $7 a share, down from prior guidance of $7.00 to $7.10 a share. CEO Kristin Peck said in the earnings release “the first quarter unfolded in a more challenging operating environment than we anticipated. Pet owners demonstrated increased price sensitivity, resulting in a decline in veterinary visits and softer demand[.]”On this news, the price of Zoetis shares declined by $23.91 per share, or 21.50%, to close at $87.31 on May 7, 2026.Contact Us To Participate or Learn More: If you purchased Zoetis securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact us: Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020, Telephone: (215) 638-4847 Email: howardsmith@howardsmithlaw.com, Visit our website at: www.howardsmithlaw.com.This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules. <img src="https://imageproxy.pbkrs.com/https://cts.businesswire.com/ct/CT/query-ZGlzdHJvPW54JmlkPWJ3bmV3cyZsYW5nPWVuJnNpZD1tc3RyMyZzdHk9MjAyNjA1MTg3NTgzMjhyMQ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" original-src="https://imageproxy.pbkrs.com/https://cts.businesswire.com/ct/CT/query-ZGlzdHJvPW54JmlkPWJ3bmV3cyZsYW5nPWVuJnNpZD1tc3RyMyZzdHk9MjAyNjA1MTg3NTgzMjhyMQ"/>Law Offices of Howard G. Smith Howard G. Smith, Esquire 215-638-4847 howardsmith@howardsmithlaw.com www.howardsmithlaw.comView source version on businesswire.com: https://www.businesswire.com/news/home/20260518758328/en/</div></div>

碩騰

生物科技 ETF - VanEck Vectors

標普生物技術 3 倍做多 - Direxion

霍華德·G·史密斯律師事務所正在調查與碩騰（Zoetis Inc.，股票代碼：ZTS）相關的潛在證券欺詐行為，此前該公司報告 2026 年第一季度淨收入持平，為 6.01 億美元，並下調了盈利指引。消息公佈後，碩騰的股價下跌了 21.50%，至 87.31 美元。遭受損失的股東被鼓勵聯繫該律師事務所以尋求潛在索賠

Zoetis Inc. (ZTS) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation

MorningStar

標普生物技術 ETF - SPDR

醫藥突破 ETF - ALPS

醫療業 ETF - Vanguard

納斯達克生物科技指數 ETF - iShares Nasdaq

基因改革 ETF - ARK

紐交所高增長板生物技術指數 ETF - First Trust

2 倍做多納斯達克生物技術 ETF - ProShares

Invesco Nasdaq Biotechnology ETF

動態生物技術與基因組 ETF - Invesco

美國制藥 ETF - iShares

醫療業 ETF - SPDR

碩騰公司 (ZTS) 的股東若遭受損失，請聯繫霍華德·G·史密斯律師事務所以瞭解證券欺詐調查